E questo ha intaccato i profitti, come afferma Novo in una nota
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
With evidence that Ozempic can induce weight loss, even for those without diabetes, in 2021, the FDA approved a higher-dose version of Ozempic, sold under the brand name Wegovy, to treat obesity and for weight management
The approval of the Wegovy tablet was based on the international OASIS 4 clinical trial, which followed patients for 64 weeks while combining medication with structured lifestyle support
Because Lavender Sky Health lets patients choose from a pool that includes these riskier names, the network as a whole inherits the worst-actor risk in the pool, even though several individual pharmacies in it are clean